Related Experiment Video
Updated: Jul 11, 2025

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
Five Inhibitory Receptors Display Distinct Vesicular Distributions in Murine T Cells
Jiahe Lu1,2, Alisa Veler1, Boris Simonetti3
1School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Abstract:
T cells can express multiple inhibitory receptors. Upon induction of T cell exhaustion in response to a persistent antigen, prominently in the anti-tumor immune response, many are expressed simultaneously. Key inhibitory receptors are CTLA-4, PD-1, LAG3, TIM3, and TIGIT, as investigated here. These receptors are important as central therapeutic targets in cancer immunotherapy. Inhibitory receptors are not constitutively expressed on the cell surface, but substantial fractions reside in intracellular vesicular structures. It remains unresolved to which extent the subcellular localization of different inhibitory receptors is distinct. Using quantitative imaging of subcellular distributions and plasma membrane insertion as complemented by proximity proteomics and biochemical analysis of the association of the inhibitory receptors with trafficking adaptors, the subcellular distributions of the five inhibitory receptors were discrete. The distribution of CTLA-4 was most distinct, with preferential association with lysosomal-derived vesicles and the sorting nexin 1/2/5/6 transport machinery. With a lack of evidence for the existence of specific vesicle subtypes to explain divergent inhibitory receptor distributions, we suggest that such distributions are driven by divergent trafficking through an overlapping joint set of vesicular structures. This extensive characterization of the subcellular localization of five inhibitory receptors in relation to each other lays the foundation for the molecular investigation of their trafficking and its therapeutic exploitation.
Insights
T cells express multiple inhibitory receptors like CTLA-4, PD-1, LAG3, TIM3, and TIGIT. Their distinct subcellular distributions are driven by unique trafficking pathways, crucial for cancer immunotherapy targets.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- T cells express multiple inhibitory receptors, including CTLA-4, PD-1, LAG3, TIM3, and TIGIT.
- These receptors are critical therapeutic targets in cancer immunotherapy, particularly in anti-tumor responses.
- The subcellular localization and trafficking of these receptors remain incompletely understood.
Purpose of the Study:
- To investigate the distinct subcellular distributions of five key inhibitory T cell receptors.
- To elucidate the trafficking mechanisms that drive these divergent distributions.
- To provide a foundation for therapeutic exploitation of inhibitory receptor trafficking.
Main Methods:
- Quantitative imaging of subcellular distributions and plasma membrane insertion.
- Proximity proteomics to analyze receptor associations.
- Biochemical analysis of inhibitory receptor association with trafficking adaptors.
Main Results:
- The five inhibitory receptors exhibited discrete subcellular distributions.
- CTLA-4 showed the most distinct distribution, associating with lysosomal-derived vesicles and sorting nexin machinery.
- Divergent trafficking through shared vesicular structures, rather than specific vesicle subtypes, likely drives distinct receptor distributions.
Conclusions:
- Subcellular localization of inhibitory T cell receptors is distinct and influenced by divergent trafficking pathways.
- Understanding these trafficking mechanisms is essential for optimizing cancer immunotherapy strategies.
- This study provides a molecular basis for investigating and targeting T cell inhibitory receptor trafficking.
More Related Videos
08:57Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
07:17Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016